Clinical Trial Update: Treat-and-extend Using Aflibercept for Type 3 Neovascularization [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating treat-and-extend using aflibercept for retinal angiomatous proliferation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Angiomatous Proliferation

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Kim's Eye Hospital | Conditions: Retinal Angiomatous Proliferation | Phase 4 | Status: UNKNOWN